Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: $APH.TO, TSX: $TGOD.TO, CSE: $MTEC.C, CSE: $CHV.C, CSE: $CROP.C

July 17th Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH podcasts


Pt. Roberts, WA; Delta, BC - July 17, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, release today's edition of its series, potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: APH, TSX: TGOD, CSE:MTEC, CSE:CHV, CSE:CROP

Today's podcast overview/transcript:

Good morning and welcome to another potcast - looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today's potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP. Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company's patented technology changes the way Active Pharmaceutical Ingredients ("APIs") enter the body orally:

1) Masks unwanted tastes - eliminates the need for sugar-filled edibles.

2) Reduces time of onset - effects are felt within 15-20 min vs. 60-120 min.

3) Avoids first-pass liver metabolism

4) Increases bio-absorption by 5-10X

The Company's DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.

Learn more about Lexaria at

Today's podcast features announcements from Aphria Inc. trading on the TSX as APH and US OTC as APHQF, The Green Organic Dutchman Holdings Ltd. trading on the TSX as TGOD, Cannvas MedTech Inc. trading on the CSE as MTEC, Canada House Wellness Group Inc. trading on the CSE as CHV and CROP Infrastructure Corp. trading on the CSE as CROP and the OTC as CRXPF.

But first, with Canada's legalization fast approaching, a new poll from YouGov Omnibus finds that nearly two in five Americans (38%) say that the new law will have a positive effect on Canada's future. Less than a quarter (24%) say that legalization will negatively affect the nation and a fifth (20%) say it will have no effect.

Positive perception of Canada's legalization of marijuana is highest among those who live in the West (41%). This comes as little surprise, given that six states in this region have legalized both recreational and medical marijuana.

By party affiliation, nearly one in two Republicans (49%) believe that legalization will have a negative impact on Canada's future. One in three independents (36%) and one in two Democrats (50%) hold that the matter will have a positive effect, the leading response for both parties.

Optimism for Canada's new legislation appears to increase with income level. Starting with those who earn less than $40,000 a year, 36% have a positive perception of the law. That figure increases to 38% when those who earn $40,000 to $80,000 are asked and culminates at 41% when those who earn over $80,000 are examined.

Aphria Inc. announced that the Company's planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia, Argentina, Jamaica and a right of first offer and refusal in respect of Brazil through a definitive share purchase agreement with Scythian Biosciences Inc. Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc., a direct, wholly-owned subsidiary of Scythian.

Highlights of the Transaction include:

  • Solidifies Aphria's leadership position in the global cannabis industry
  • Provides Aphria with world class assets in the most advanced regulatory jurisdictions across LATAM and Caribbean markets, from which it can further grow and expand its international operations
  • Strengthens Aphria's leading international management team with the addition of proven local LATAM and Caribbean executives
  • Establishes Aphria's presence in the most advanced strategic market in South America, Colombia
  • Gains first mover advantage in Argentina for eventual in country cultivation
  • Acquires market leadership in Jamaica with the only producing Tier 3 cultivator license in the country
  • Yields strategic rights to potentially expand into Brazil, the largest population in South America
  • Delivers accretive cash flow beginning in calendar 2019

The Green Organic Dutchman Holdings Ltd. announced, in conjunction with Epican Medicinals ("Epican"), the successful opening of its first legal cannabis retail store in Jamaica, on Saturday, July 14th. This flagship location provides Epican and TGOD with immediate revenue from the sale of premium Jamaican grown organic cannabis and further exemplifies TGOD's value-added approach to partnerships.

The ~4,000 sq. ft. flagship dispensary in Kingston represents the first of several Epican Herb Houses scheduled to be completed across Jamaica by the end of 2018. These locations will serve the medical needs of Jamaica's 3 million residents and over 3.5 million visitors each year.

Cannvas MedTech Inc., a leading business technology company within the cannabis space, announced the appointment of Radu Puscasu as Data Protection Officer. With over 14 years of experience, Radu has been heavily involved in creating meaningful customer relationship experiences through secure technology. He has held senior roles at Bell Media, TD Bank Securities (Equity Derivative Solutions and Data Management Services), and Pitney Bowes and has worked with client companies such as Takeda, AstraZenaca, Pfizer, and Novartis.

Cannvas also announced its intention to expand into Germany, one of the fastest growing medical cannabis marketplaces in the world. The country has fully embraced medical cannabis as a legitimate, doctor-prescribed, insurance-paid, and pharmacy-provided medical and healthcare product.

Canada House Wellness Group Inc. announced that it has entered into, through its wholly owned subsidiary Abba Medix Corp., an exclusive licensing agreement with Medicine Man Technologies Inc. (OTCQB:MDCL), one of the United States' leading cannabis branding and consulting companies, for deployment of its intellectual property and product lines (Three a Light ®, Success Nutrients ®, General Intellectual Property) into the Canadian marketplace.

The licensing agreement calls for payment of $4.65M (CAD) in the form of cash and stock for licensing of Medicine Man's intellectual property, product lines, and assignment of an existing Cultivation MAX agreement to Canada House.

CROP Infrastructure Corp. announced today that it has completed the retrofit and upgrades at its 'The Park' state-of-the-art facility in Washington State. Crop's licensed tenant grower there has now advised that it expects to harvest an initial 350 pounds of high quality cannabis within six weeks and will be at full scale production in September 2018.

The Park cannabis greenhouse is 35,000 sqft and sits on approximately nine acres of land. The facility recently underwent a complete retro-fit for hydroponic automation and the addition of 500 Gavita HPS grow lights. The greenhouse facility has five flowering bays that are designed to yield, at full scale production, approximately 12,000 pounds of high quality cannabis annually (~1,000 pounds per month). The facility requires no additional capex for upgrades in order that the tenant may reach full commercial production.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas potcasts

Subscribe to the new cannabis podcast series:

Or visit


To hear more podcasts visit: podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Ideas is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors. cannabis/marijuana and hemp content now includes on the news and stock directory pages, a cannabis investor group on , the 420 Cannabis Investor ideas, and the new AI site Global Cannabis Investing at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Disclosure Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy:

To sponsor this podcast or be a guest



Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks

Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing